Michael D Decker
Overview
Explore the profile of Michael D Decker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
48
Citations
883
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Decker M
Reprod Toxicol
. 2024 Jun;
129:108627.
PMID: 38823463
In the recent paper by Lee et al. reporting reproductive toxicity testing of BVN008, a newly developed tetanus, diphtheria, and acellular pertussis vaccine, the statement is made "BVN008 is a...
2.
3.
Decker M, Edwards K
J Infect Dis
. 2021 Sep;
224(12 Suppl 2):S310-S320.
PMID: 34590129
Pertussis (whooping cough) is a respiratory infection caused by Bordetella pertussis. All ages are susceptible. In the prevaccine era, almost all children became infected. Pertussis is particularly dangerous in young...
4.
Decker M, Garman P, Hughes H, Yacovone M, Collins L, Fegley C, et al.
Vaccine
. 2021 Aug;
39(39):5541-5547.
PMID: 34454787
Objectives: To evaluate the rates of myopericarditis (primary objective) and rates of cardiovascular and neurological adverse events (secondary objectives) in temporal association with ACAM2000® smallpox vaccine. Methods: Observational cohort study...
5.
Hansen J, Decker M, Lewis E, Fireman B, Pool V, Greenberg D, et al.
Pediatr Infect Dis J
. 2021 Aug;
40(12):1122-1126.
PMID: 34420008
Background: Hypotonic-hyporesponsive episode (HHE) after whole cell pertussis vaccination is a known adverse event. Less is known about the risk of HHE after administration of acellular pertussis vaccines. Methods: Using...
6.
Faix D, Gordon D, Perry L, Raymond-Loher I, Tati N, Lin G, et al.
Vaccine
. 2020 Sep;
38(46):7323-7330.
PMID: 32967791
Objectives: To compare rates of myopericarditis, severe and serious dermatological or neurological events, and other adverse events in deploying US military personnel who received or did not receive ACAM2000® (Smallpox...
7.
Conway J, Davis J, Eickhoff J, Pool V, Greenberg D, Decker M
Vaccine
. 2020 Sep;
38(45):7063-7069.
PMID: 32921507
Background: Acellular pertussis vaccines were initially licensed based on placebo-controlled efficacy trials, but such trials are no longer ethical. The effectiveness of current pertussis vaccines among properly vaccinated children <5 ...
8.
Decker M, Morton C, Moncayo A
Clin Infect Dis
. 2020 May;
71(12):3237-3240.
PMID: 32459327
Heartland virus is a tickborne phlebovirus first identified in Missouri in 2009; 11 human cases have been reported in the literature. Reported hallmarks of infection have included fever, malaise, anorexia,...
9.
Decker M, Greenberg D, Johnson D, Pool V
Vaccine
. 2019 Jul;
37(35):5003-5008.
PMID: 31301919
Background: It has been reported that persons primed with acellular (DTaP) pertussis vaccines have reduced duration of pertussis protection compared with those primed with whole-cell (DTwP) vaccines. However, due to...
10.
Chit A, Zivaripiran H, Shin T, Lee J, Tomovici A, Macina D, et al.
PLoS One
. 2018 Jun;
13(6):e0197970.
PMID: 29912887
Background: Acellular pertussis vaccine studies postulate that waning protection, particularly after the adolescent booster, is a major contributor to the increasing US pertussis incidence. However, these studies reported relative (ie,...